Advancing cancer research
June 24, 2026
A researcher’s gloved hands hold a sample testing dish with multiple wells filled with dark pink fluid at the OHSU Knight Cancer Research Building. Knight Cancer Institute labs span areas from biomedical engineering to childhood cancer, working to advance cancer research. (OHSU/Christine Torres Hicks)
Knight Cancer Institute - innovative research
June 24, 2026
The Knight Cancer Institute wall sign inside the Knight Cancer Research Building at OHSU. The institute includes more than 900 researchers across over 120 units, including faculty, postdoctoral scholars, scientists, technicians, technologists, computational biologists and biostatisticians. (OHSU/Christine Torres Hicks)
Improving safety, efficacy in cancer treatment
June 24, 2026
An OHSU research team has developed a new nanoparticle that could make cancer treatment safer and more effective. (OHSU/Christine Torres Hicks)
OHSU Knight Cancer Research Building
June 24, 2026
The OHSU Knight Cancer Research building in Portland. The OHSU Knight Cancer Institute offers the latest treatments and technologies as well as hundreds of research studies and clinical trials. (OHSU/Christine Torres Hicks)
Give Cancer Hell - Knight Cancer Institute logo
June 24, 2026
New developments in cancer
June 24, 2026
OHSU cancer researchers have developed PAC-MANN, a blood test that detects changes in protease activity, a key indicator of the most common and deadliest form of pancreatic cancer. (OHSU/Christine Torres Hicks)
New drug combinations could improve therapies for breast cancer other aggressive cancers
June 24, 2026
Brian Druker M.D. (OHSU)
June 24, 2026
OHSU Knight Cancer Institute 2
June 24, 2026
OHSU Knight Cancer Institute
June 24, 2026
